International health experts released a new report today in Stockholm titled "Smoke-free, Reduce Harm", which provides compelling evidence that despite similar levels of nicotine consumption, Sweden has significantly lower rates of tobacco-related diseases compared to other European countries.
The report was published during an event by the Global Health Advocacy Organization Smokefree Sweden, detailing nicotine use rates in Sweden and many similar countries, finding that nicotine use is not a factor in tobacco-related diseases. Furthermore, the report further demonstrates that it is the method of consumption that affects consumer health. While using alternative products such as snus does not pose significant risks, smoking is linked to high rates of death and disease.
Despite having a nicotine consumption rate similar to the European average, Sweden has a lung cancer incidence rate 41% lower than other European countries and a tobacco-related death toll less than half of that in European nations. This stark contrast is attributed to the widespread use of smokeless nicotine products such as snus, nicotine pouches, and e-cigarettes.
"The difference between smoking and using smoke-free products is crucial," said Dr. Karl Fagerström, a public health expert and author of the report. "While nicotine is addictive, it does not lead to serious smoking-related diseases. Our research results support shifting the focus from quitting smoking to using less harmful alternatives for those who cannot quit completely."
Sweden has taken proactive measures in public health education and regulatory frameworks to encourage transitioning to these alternative options, with significant impact on public health outcomes. The report highlights that adopting similar harm reduction strategies could be crucial for other countries' efforts to reduce the health impacts of tobacco use.
Dr. Karl added: "The experience in Sweden shows that understanding and addressing misconceptions about nicotine among the public can lead to better consumer protection and informed public health policies."
Notice
1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.
2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.
3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.
Copyright
This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.
This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.
